Related Experiment Video
Updated: May 25, 2026
07:45
"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
Published on: November 28, 2025
[Thyroid cancer--the malignant lesions in the contralateral lobe]
F Vărcuş1, D Bordoş, M Cornianu
1Clinica 2 Chirurgie, Spitalul Judeţean de Urgenţă, Timişoara, România. varcus.florian@yahoo.com
Chirurgia (Bucharest, Romania : 1990)
|February 8, 2012
Summary
Completion thyroidectomy for ipsilateral thyroid cancer reveals a high frequency of contralateral lesions, especially in tumors larger than 1 cm. This finding supports total thyroidectomy for these patients to ensure comprehensive cancer management.
Area of Science:
- Endocrinology
- Oncology
- Surgical Pathology
Context:
- Thyroid cancer management often involves initial lobectomy.
- Completion thyroidectomy is performed for residual or new contralateral disease.
- Determining the extent of thyroid surgery is crucial for patient outcomes.
Purpose:
- To assess the incidence of contralateral thyroid cancer after ipsilateral lobectomy.
- To identify criteria for recommending total thyroidectomy in thyroid cancer patients.
- To evaluate the risk of contralateral malignancy based on primary tumor size.
Summary:
- A retrospective study of 228 patients undergoing completion thyroidectomy for ipsilateral thyroid cancer was conducted.
- Contralateral thyroid cancer was detected in 41.2% of cases.
- Malignant lesions in the contralateral lobe were found in 4.7% of patients with ipsilateral tumors < 1 cm and 42.8%-47.6% for tumors > 1 cm.
Impact:
- The high rate of contralateral disease in tumors > 1 cm suggests total thyroidectomy is indicated.
- Findings can refine surgical guidelines for thyroid cancer treatment.
- Improved patient stratification for surgical intervention in thyroid cancer.
Related Concept Videos
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...